Adverse Respiratory Reactions to Tyrosine Kinase Inhibitors: A Disproportionality Analysis of Spontaneous Reports from European Countries
The results indicate that respiratory disorders induced by the TKIs dasatinib and bosutinib need to be diagnosed in a timely manner, and suggest that caution should be taken when prescribing these TKIs to patients affected by CML and pulmonary comorbidities.
Authors
- Fabrizio Calapai (ORCID: https://orcid.org/0000-0003-2868-1066)
- Ilaria Ammendolia (ORCID: https://orcid.org/0000-0002-4075-8065)
- Carmen Mannucci (ORCID: https://orcid.org/0000-0003-1292-6284)
- G. Calapai
- C Mondello
- Mariaconcetta Currò
- Paola Midiri
- Antonino Cancellieri
- Emanuela Esposito
- Luigi Cardia
Institutions
- University of Messina (IT)
Publication Details
- Journal
- Life
- Published
- 2026-01-13
- DOI
- https://doi.org/10.3390/life16010113
- Citations
- 1
- Primary Topic
- Chronic Myeloid Leukemia Treatments
- Type
- article
- Field-Weighted Citation Impact
- 35.41